Brief: Annovis Bio Announces Completion Of Phase III Parkinson's Disease Treatment Enrollment At Record Pace
08/06/2023 12:34
June 8 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO ANNOUNCES COMPLETION OF PHASE III PARKINSON'S
DISEASE TREATMENT ENROLLMENT AT RECORD PACE
Source text for Eikon: ID:nPn9ZmkSLa
Further company coverage: ANVS.N
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman